Cargando…

Prevention of EAE by tolerogenic vaccination with PEGylated antigenic peptides

BACKGROUND: Therapeutic treatment options for chronic autoimmune disorders such as multiple sclerosis (MS) rely largely on the use of non-specific immunosuppressive drugs, which are not able to cure the disease. Presently, approaches to induce antigen-specific tolerance as a therapeutic approach; fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pfeil, Jennifer, Simonetti, Mario, Lauer, Uta, von Thülen, Bianca, Durek, Pawel, Poulsen, Christina, Pawlowska, Justyna, Kröger, Matthias, Krähmer, Ralf, Leenders, Frank, Hoffmann, Ute, Hamann, Alf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366199/ https://www.ncbi.nlm.nih.gov/pubmed/34408824 http://dx.doi.org/10.1177/20406223211037830

Ejemplares similares

Tolerogenic Immunomodulation by PEGylated Antigenic Peptides
por: Pfeil, Jennifer, et al.
Publicado: (2020)

Peptides reloaded - new strategies for tolerogenic vaccination
por: Hamann, Alf, et al.
Publicado: (2011)

Facilitated Peptide Transport via the Mucosal Epithelium: Impact on Tolerance Induction
por: Kenngott, Elisabeth E., et al.
Publicado: (2017)

Regulation and Migratory Role of P-Selectin Ligands during Intestinal Inflammation
por: Hoffmann, Ute, et al.
Publicado: (2013)

Tolerogenic nanoparticles mitigate the formation of anti-drug antibodies against pegylated uricase in patients with hyperuricemia
por: Sands, Earl, et al.
Publicado: (2022)

Targeting IFN activity to both B cells and plasmacytoid dendritic cells induces a robust tolerogenic response and protection against EAE
por: Cauwels, Anje, et al.
Publicado: (2021)

Induction of Tolerogenic Dendritic Cells by a PEGylated TLR7 Ligand for Treatment of Type 1 Diabetes
por: Hayashi, Tomoko, et al.
Publicado: (2015)

Rethinking EAE pathogenesis
por: Van Epps, Heather L.
Publicado: (2005)

PARing down EAE
por: Van Epps, Heather L.
Publicado: (2006)

Tolerogenic therapies in transplantation
por: Page, Eugenia K., et al.
Publicado: (2012)

Thomas Rivers and the EAE model
por: Van Epps, Heather L.
Publicado: (2005)

Role of Microglia and Macrophages in Eae
por: Raivich, Gennadij, et al.
Publicado: (2005)

Neuroantigen-specific, tolerogenic vaccines: GM-CSF is a fusion partner that facilitates tolerance rather than immunity to dominant self-epitopes of myelin in murine models of experimental autoimmune encephalomyelitis (EAE)
por: Abbott, Derek J, et al.
Publicado: (2011)

CNS Pericytes Modulate Local T Cell Infiltration in EAE
por: Koch, Kathrin, et al.
Publicado: (2022)

Tolerogenic vaccines for Multiple Sclerosis
por: Mannie, Mark D., et al.
Publicado: (2013)

Tolerogenic citrullinated peptide for arthritis
por: Gertel, Smadar, et al.
Publicado: (2015)

NLRP3 Inflammasome and MS/EAE
por: Inoue, Makoto, et al.
Publicado: (2013)

The EAES intellectual property awareness survey
por: Nakajima, Kiyokazu, et al.
Publicado: (2021)

Overexpression of GSN could decrease inflammation and apoptosis in EAE and may enhance vitamin D therapy on EAE/MS
por: Gao, Jifang, et al.
Publicado: (2017)

Human Cytomegalovirus Drives Epigenetic Imprinting of the IFNG Locus in NKG2C(hi) Natural Killer Cells
por: Luetke-Eversloh, Merlin, et al.
Publicado: (2014)

Phase 2 Dose-Finding Study in Patients with Gout Using SEL-212, a Novel PEGylated Uricase (SEL-037) Combined with Tolerogenic Nanoparticles (SEL-110)
por: Kivitz, Alan, et al.
Publicado: (2023)

Direct modulation of myelin-autoreactive CD4(+) and CD8(+) T cells in EAE mice by a tolerogenic nanoparticle co-carrying myelin peptide-loaded major histocompatibility complexes, CD47 and multiple regulatory molecules
por: Pei, Weiya, et al.
Publicado: (2018)

Tolerogenicity of resting and activated B cells
Publicado: (1994)

Tolerogenic dendritic cell-based immunotherapy
por: Chang, Kiyuk, et al.
Publicado: (2017)

Tolerogenic vaccines for the treatment of cardiovascular diseases
por: Vigario, Fernando Lozano, et al.
Publicado: (2020)

The Effects of Tamoxifen on Tolerogenic Cells in Cancer
por: Mohd Idris, Ros Akmal, et al.
Publicado: (2022)

Chemokine receptor expression by inflammatory T cells in EAE
por: Mony, Jyothi Thyagabhavan, et al.
Publicado: (2014)

Notch Signaling and T-Helper Cells in EAE/MS
por: Bassil, Ribal, et al.
Publicado: (2013)

Neutrophil-related factors as biomarkers in EAE and MS
por: Rumble, Julie M., et al.
Publicado: (2015)

Operating hurts: a study of EAES surgeons
por: Wells, Antonia C., et al.
Publicado: (2018)

Mechanisms of sex hormones in autoimmunity: focus on EAE
por: Lasrado, Ninaad, et al.
Publicado: (2020)

Coreceptor therapy has distinct short- and long-term tolerogenic effects intrinsic to autoreactive effector T cells
por: Clark, Matthew, et al.
Publicado: (2021)

Regulatory Multitasking of Tolerogenic Dendritic Cells – Lessons Taken from Vitamin D3-Treated Tolerogenic Dendritic Cells
por: Nikolic, Tatjana, et al.
Publicado: (2013)

TRANSFORMATION OF A HISTOCOMPATIBILITY IMMUNOGEN INTO A TOLEROGEN
por: Nimelstein, Stephen H., et al.
Publicado: (1973)

Inducing a tolerogenic microenvironment within tissues
por: Cobbold, Stephen P
Publicado: (2011)

Tolerogenic function of Blimp-1 in dendritic cells
por: Kim, Sun Jung, et al.
Publicado: (2011)

Tolerogenic function of Blimp-1 in dendritic cells
por: Kim, Sun Jung, et al.
Publicado: (2012)

Tolerogenic and Activatory Plasmacytoid Dendritic Cells in Autoimmunity
por: Guéry, Leslie, et al.
Publicado: (2013)

Generation of Tolerogenic Dendritic Cells and Their Therapeutic Applications
por: Yoo, Seungbo, et al.
Publicado: (2016)

Metabolism Is Central to Tolerogenic Dendritic Cell Function
por: Sim, Wen Jing, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_48a4kh5j72atf58jtcuf1ks4f4